| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-135 |
Sentence |
denotes |
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation. |
| T1 |
0-135 |
Sentence |
denotes |
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation. |
| TextSentencer_T2 |
136-295 |
Sentence |
denotes |
The primary role of protooncogene c-kit in mast cell differentiation is supported by the development of mast cells from CD34+/CD117+(c-kit) myeloid precursors. |
| T2 |
136-295 |
Sentence |
denotes |
The primary role of protooncogene c-kit in mast cell differentiation is supported by the development of mast cells from CD34+/CD117+(c-kit) myeloid precursors. |
| TextSentencer_T3 |
296-502 |
Sentence |
denotes |
Growth factor independence, neoplastic transformation and differentiation of mast cells were found in association with c-kit activating mutations in both murine and human mastocytoma and mast cell diseases. |
| T3 |
296-502 |
Sentence |
denotes |
Growth factor independence, neoplastic transformation and differentiation of mast cells were found in association with c-kit activating mutations in both murine and human mastocytoma and mast cell diseases. |
| TextSentencer_T4 |
503-704 |
Sentence |
denotes |
We have identified a novel c-kit mutation (D816Y) in peripheral blood mononuclear cells from a patient with AML (M2), massive presence of mast cells in bone marrow and rapid progression of the disease. |
| T4 |
503-704 |
Sentence |
denotes |
We have identified a novel c-kit mutation (D816Y) in peripheral blood mononuclear cells from a patient with AML (M2), massive presence of mast cells in bone marrow and rapid progression of the disease. |
| TextSentencer_T5 |
705-964 |
Sentence |
denotes |
The mutation, a G-->T transversion at nt 2467 of the c-kit gene resulting in Asp816-->Tyr substitution, corresponds to the D814Y and D817Y mutations identified and characterized in the murine P815 mastocytoma and the rat RBL-2H3 mast cell leukemia cell lines. |
| T5 |
705-964 |
Sentence |
denotes |
The mutation, a G-->T transversion at nt 2467 of the c-kit gene resulting in Asp816-->Tyr substitution, corresponds to the D814Y and D817Y mutations identified and characterized in the murine P815 mastocytoma and the rat RBL-2H3 mast cell leukemia cell lines. |
| TextSentencer_T6 |
965-1132 |
Sentence |
denotes |
The absence of SCF transcripts that we found by RTPCR in the patient's blasts indicates that, also in humans, this activating mutation leads to SCF independent growth. |
| T6 |
965-1132 |
Sentence |
denotes |
The absence of SCF transcripts that we found by RTPCR in the patient's blasts indicates that, also in humans, this activating mutation leads to SCF independent growth. |
| TextSentencer_T7 |
1133-1287 |
Sentence |
denotes |
The expression of the mutant allele on Kit signaling may be further enhanced by trisomy of chromosome 4 (carrying the c-kit gene) in the patient's blasts. |
| T7 |
1133-1287 |
Sentence |
denotes |
The expression of the mutant allele on Kit signaling may be further enhanced by trisomy of chromosome 4 (carrying the c-kit gene) in the patient's blasts. |
| TextSentencer_T8 |
1288-1564 |
Sentence |
denotes |
From these findings it is concluded that mast cells could be generated from a leukemic CD34/CD117-positive clone, that combines the antigenic expression of mast cell precursor to the growth and differentiation factor-independence which was derived by the c-kit D816Y mutation. |
| T8 |
1288-1564 |
Sentence |
denotes |
From these findings it is concluded that mast cells could be generated from a leukemic CD34/CD117-positive clone, that combines the antigenic expression of mast cell precursor to the growth and differentiation factor-independence which was derived by the c-kit D816Y mutation. |